公開セミナーのお知らせ
Dr. Thierry Livache をお迎えして下記の通り公開セミナーを開催いたします。ぜひご来聴ください。
＜開催日時・会場＞
日時：2026年3月26日(木)10：00～12：00
会場：東京農工大学 小金井キャンパス新1 号館 1階グリーンホール
＜講演者・タイトル＞
◆Dr. Thierry Livache（フランス原子力・代替エネルギー庁(CEA) 、Research Director）
“Photonics for sensing : from odor imaging to bacteria and viruses detection”
＜Abstract＞
Olfaction is the sense that allows us to smell odors. It is naturally a very complex process, which translates olfactory stimulation into behavior or, more simply, into a more or less specialized vocabulary. A more objective approach can be achieved in some cases by biomimetic instruments that digitize odors. Thus, biomimetic systems can be designed that, based on multiple molecular recognitions, transform a smell into an image that is easier to analyze. The optical strategies including plasmonic or interferometric approaches developed by Olfaktion (former Aryballe) will be explained and examples of commercial applications will be shown. More recently, based on the same plasmonic principles, a new approach enabling the individual detection of biological particles, mainly bacteria and viruses , has emerged and currently applied for medical purposes.
References :
1. https://olfaktion.com/
2. Maho, Pierre et al. Reliable chiral recognition with an electronic nose, Biosensors and Bioelectronics,112183,2020,
3. Laplatine et al. Silicon photonic olfactory sensor based on an array of 64 biofunctionalized Mach-Zehnder interferometers. Optics Express, 19, 33955-33968 (2022)
4. A. Fournel et al. An experimental investigation comparing a surface plasmon resonance imaging-based artificial nose with natural olfaction. Volume 320, 1 October (2020)
CV
Dr.Thierry Livache, (PharmD, Hab.) is a Research Director at CEA. He had been a senior R&D scientist in a pharmaceutical company, CIS-bio, for 10 years (1990-2000) where he had developed microsystems for biological analyses, pioneering the domain of the use of silicon chips for in vitro bio-analyses. In 2000, he came back to basic researches at CEA where he constructed and leaded the CREAB group within the joined unit Symmes (CEA, CNRS, University of Grenoble). In 2014, co-founded Aryballe (digital olfaction) where he had been the Scientific Director (CSO) from 2016 to 2022. He recently came back to the CEA-Grenoble to start a new project dealing with bacteria and viruses detection and quantification for clinical applications.
His expertise includes the development of micro-bioanalytical tools at the interface of physics, chemistry and biology and their clinical applications.
He cofounded three companies Genoptics (SPR imaging now included in the Horiba Scientific Group) in 2002, PrestoDiag in 2012 (plasmonic-based bacteria detection), and Aryballe in 2014.
He is the author of more than 120 peer-reviewed publications ~60 invited conferences and ~40 families of patents. H-index 46 (Google Scholar).
●言語：英語
●どなたでも、ご参加いただけます。
■問い合わせ先
工学研究院 清水 大雅
h-shmz (ここに＠を入れてください）cc.tuat.ac.jp